Abstract
In the past 20 years, numerous percutaneous vascular closure devices have been tested and compared with manual compression and to surgical cut-down. The suture-mediated closure device Perclose ProGlide™ system (Abbott Vascular, CA, USA) emerged as a safe and effective alternative for many procedures requiring either small or large bore vascular accesses. In this review, we will discuss the characteristics of this vascular closure device and the main studies that proved its potential to reduce vascular complications, time to deambulation, time to discharge and patient discomfort.
Author contributions
A Del Prete had full access to all the data in the study and takes full responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design was provided by A Del Prete. Acquisition, analysis or interpretation of data were performed by A Del Prete, DG Della Rocca, S Calcagno, R Di Pietro, A Natale and F Versaci. The manuscript was drafted by A Del Prete, DG Della Rocca, Calcagno, R Di Pietro, G Del Prete, G Biondi-Zoccai, M Raponi, M Scappaticci, A Di Matteo, A Natale and F Versaci. Critical revision of the manuscript for important intellectual content was performed by A Del Prete, DG Della Rocca, S Calcagno, R Di Pietro, G Del Prete, G Biondi-Zoccai, M Raponi, M Scappaticci, A Di Matteo, A Natale and F Versaci. Administrative, technical or material support was provided by A Del Prete, DG Della Rocca, S Calcagno, A Natale and F Versaci. Study supervision was performed by A Del Prete, G Della Rocca, S Calcagno, R Di Pietro, G Del Prete, G Biondi-Zoccai, M Raponi, M Scappaticci, A Di Matteo, A Natale and F Versaci.
Financial & competing interests disclosure
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.